Skip to main content
. Author manuscript; available in PMC: 2014 Oct 29.
Published in final edited form as: Laryngoscope. 2010 Oct;120(10):1990–1997. doi: 10.1002/lary.21089

Table 3.

Demographics and Exposure Characteristics of Patients with Incident NPC (1999-2008) for Whom Pathology Specimens Were Available for HPV Testing.

No. of Patients (%)

Characteristic All
(n = 30)
WHO Type I
(n = 8)
WHO Type II/III
(n = 22)
P value*
Age, years
 <30 4 (13.3) 0 (0) 4 (18.2) .230
 30-59 15 (50.0) 3 (37.5) 12 (54.5)
 ≥60 11 (36.7) 5 (62.5) 6 (27.3)
Sex
 Male 22 (73.3) 6 (75.0) 16 (72.7) 1.0
 Female 8 (26.7) 2 (25.0) 6 (27.3)
Ethnicity
 Non-Hispanic White 19 (63.3) 6 (75.0) 13 (59.1) .851
 Asian 5 (16.7) 1 (12.5) 4 (18.2)
 Other 6 (20.0) 1 (12.5) 5 (22.7)
Smoking
 Never 13 (43.3) 2 (25.0) 11 (50.0) .441
 Former 7 (23.3) 2 (25.0) 5 (22.7)
 Current 10 (33.3) 4 (50.0) 6 (27.3)
Pack-years of ever smokers
 <30 pack-years 7 (23.3) 0 (0) 7 (31.8) .035
 ≥30 pack-years 10 (33.3) 6 (75.0) 4 (18.2)
Alcohol use
 Never/rare 18 (60.0) 5 (62.5) 13 (59.1) .059
 Former 5 (16.7) 3 (37.5) 2 (9.1)
 Current 7 (23.3) 0 (0) 7 (31.8)
History of cancer in first-degree relative
 None 15 (50.0) 2 (25.0) 13 (59.1) .215
 Any cancer 15 (50.0) 6 (75.0) 9 (40.9)

WHO = World Health Organization.

*

Fisher's exact test comparing WHO type I to WHO type II/III.

Includes one WHO-I NPC patient with prevalent disease.